https://www.ampulmonary.com/copd/article/22971000/usage-of-copd-treatment-options-lower-among-black-populationPulmonaryen2026-07-21T18:37:46.000ZUsage of COPD treatment options lower among Black populationhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/copd-black-population.ORNgZl3Mow.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22970997/virtual-reality-could-help-ease-anxiety-and-depression-in-copd-patientsPulmonaryen2026-07-21T18:34:21.000ZVirtual reality could help ease anxiety and depression in COPD patientshttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/vr-anxiety.tHjfZTV4Av.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/pulmonary/article/22970733/silicosis-breakthrough-epithelial-cells-are-key-activatorsPulmonaryen2026-07-16T20:14:42.000ZSilicosis breakthrough: Epithelial cells are key activatorshttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/michelle-and-maggiejpg.OzIMKwdHAi.webp?auto=format%252Ccompress&q=70Michelle Tate, PhD, and Maggie Lam, PhDhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/07/f-90-16-19690549-qdraammh-healthy-vs-silicosis-lung.D6uG8GITFo.jpg?auto=format%252Ccompress&q=70Gross pathology comparison of a healthy human lung (right) and a lung with advanced silicosis (left).